Results 221 to 230 of about 1,418,988 (256)

Comment on "Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis". [PDF]

J Gastroenterol Hepatol
Fatima B.
europepmc   +1 more source

Synthesis and characterization of amphiphilic nitroxide 1,1,3,3–tetraethylisoindoline–2–oxyl–5–sodium sulfonate (TEIOSNa)

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract The synthesis and characterization of an amphiphilic nitroxide to be used as a controlling agent in a nitroxide‐mediated living radical polymerization in aqueous dispersion media is presented. In the first stage of nitroxide synthesis (phthalimide protection), two reaction methods were employed: traditional and microwave.
Enrique García‐Leal, Martha Eugenia Albores Velasco, René O. Vargas, Rubén Mil‐Martínez   +3 more
wiley   +1 more source

Analysis of proton pump inhibitor-associated drug problems and contributing factors among hospitalized nephrology patients. [PDF]

Front Pharmacol
Song N, Zhang X, Han M, Guan Y.
europepmc   +1 more source

Critical mineral removal from mining‐impacted waters using microalgal biomass

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract Rising demand for critical minerals has led to increased mining and mineral processing activities, resulting in the release of metal‐contaminated waters requiring treatment. Conventional treatment methods, such as lime neutralization, effectively precipitate metals; however, they are less effective at low metal concentrations and produce large
Sean Nickson, Corey A. Laamanen, John A. Scott   +2 more
wiley   +1 more source

Combination of proton-pump inhibitor and anti-CD3 F(ab')₂ for islet neogenesis and immune modulation in type 1 diabetes. [PDF]

Immunother Adv
Wu TY, Chen CY, Chen M, Wang CH, Kao AP, Wang KH, Chuang KH, Lin SY.   +7 more
europepmc   +1 more source

Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross‐sectional study

Clinical Pharmacology &Therapeutics, EarlyView.
The extent of pharmacogenetic (PGx) drug dispensing among Dutch adults receiving medications for cardiovascular disease (CVD) is unknown. Using the University of Groningen IADB.nl pharmacy database, we performed a serial cross‐sectional study (2019–2023) to estimate the annual prevalence of PGx drug dispensing and annual rates of initiation.
Zhuolin Zhang, Guiling Zhou, Jens H. J. Bos, Eelko Hak, Talitha Feenstra, Frank Klont   +5 more
wiley   +1 more source

Proton Pump Inhibitor Use and Survival Outcomes in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Immunotherapy: A Real-World Study. [PDF]

Medicina (Kaunas)
Karatlı S, Kaya S, Çelik S, İlhan A, Yıldırım ÖA.   +4 more
europepmc   +1 more source

Association of Long-Term Proton Pump Inhibitor Use With Nutrient Deficiencies: A Retrospective Cross-Sectional Study. [PDF]

Cureus
Nafea S, Iguh C, Waseem F, Babar T, Masood MH, Ali MA, Bashir Ahmed F, Qasem H, George Cherian N, Ibrahem Atoom G, Ibrahim Atoum B.   +10 more
europepmc   +1 more source

Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study. [PDF]

Ann Hematol
Mueller S, Pan CC, Bosák J, Hofmann J, Losch FO, Wilke T, Deiters B, Žáčková D.   +7 more
europepmc   +1 more source

Proton pump inhibitor use is not independently associated with colonic diverticulosis in an asymptomatic screening population. [PDF]

Sci Rep
Völkerer A, Wernly S, Semmler G, Flamm M, Ausserwinkler M, Koch G, Götz N, Hofer H, Aigner E, Datz C, Wernly B.   +10 more
europepmc   +1 more source